Circulating malignant precursors in monoclonal gammopathies

Eur J Haematol Suppl. 1989:51:27-9. doi: 10.1111/j.1600-0609.1989.tb01488.x.

Abstract

Peripheral blood mononuclear cells (PBMC) from 14 patients with multiple myeloma (MM), 3 patients with benign monoclonal gammopathy, 3 patients with Waldenstrom's macroglobulinaemia (WM) and 2 patients with B-cell chronic lymphocytic leukemia (B-CLL) were cultured in vitro in the presence of IL-3 and IL-6. After 3 days, actively proliferating immunoblast-like B cells were apparent in 12/14 cases of MM, 0/3 BMG, 3/3 WM and 0/2 B-CLL. After 6 d, B blasts had evolved into morphologically evident plasma cells expressing the specific monoclonal light and heavy chains. The data indicate that the concerted action of IL-3 and IL-6 synergistically promotes the proliferation and differentiation of circulating plasmacell precursors in malignant monoclonal gammopathies.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation / drug effects
  • Cell Division / drug effects
  • Drug Synergism
  • Humans
  • Interleukin-3 / pharmacology
  • Interleukin-6 / pharmacology
  • Leukemia, Lymphocytic, Chronic, B-Cell / blood*
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Neoplastic Cells, Circulating* / drug effects
  • Neoplastic Cells, Circulating* / pathology
  • Neoplastic Stem Cells / drug effects
  • Paraproteinemias / blood*
  • Paraproteinemias / pathology
  • Tumor Cells, Cultured / drug effects

Substances

  • Interleukin-3
  • Interleukin-6